Key result
Anti-embolic protection systems are essential for improving TAVI outcomes.
Why the study?
The necessity and role of anti-embolic protection systems during transcatheter aortic valve implantation remain subject to ongoing discussion and differing specialist opinions.
Do anti-embolic protection systems provide benefit in patients undergoing transcatheter aortic valve implantation?
Do anti-embolic protection systems provide benefit in patients undergoing transcatheter aortic valve implantation?
This review discusses the pros and cons, evidence base, and expert opinions regarding the use of anti-embolic protection systems during transcatheter aortic valve implantation.
The authors discuss the need for anti-embolic protection systems for transcatheter aortic valve implantation. History of this issue is briefly described. Available evidence base and results of clinical trials are presented. Opinions of specialists in endovascular surgery and developmental trends are identified. The authors propose possible solutions and own opinions.
No takes yet. Share an insight, caveat, or question.
Kavteladze et al. (2025) studied this question. Anti-embolic protection systems are essential for improving outcomes in transcatheter aortic valve implantation procedures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: